International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10168605
Original Article
A Retrospective Multivariate Analysis of Pre and Post Pubertal Onset of Vitiligo in a Tertiary Care Center
 ,
 ,
Published
Nov. 21, 2023
Abstract

Background: Vitiligo is an acquired, progressive depigmenting disorder that presents as depigmented macules or patches. Although it may manifest at any time in life, it usually begins in childhood. There is insufficient data to compare the clinical correlations of prepubertal and post-pubertal onset vitiligo.

Objective: To compile the clinical profiles and sociodemographic parameters of vitiligo patients by the age of onset of vitiligo.

Materials and Methods: Aretrospectivehospital-based study in a tertiary care hospital, the medical records of all patients with vitiligo who attended the OPD over a period of one year were analyzed.

Results: Out of 307 patients, 210 had post-pubertal and 97 had pre-pubertal onsets of vitiligo. There were more females in the prepubertal group than in the post-pubertal group. Only in those with a post-pubertal onset, vitiligo universalis was observed. Segmental vitiligo was seen more in the prepubertal onset group. In univariate analysis, previous episodes of spontaneous re-pigmentation, family history of vitiligo, and canities are commonly associated with prepubertal onset. The association with type 2 diabetes in vitiligo was greater in the post-pubertal group. In multivariate analysis, halo naevi and family history of canities remained statistically significant for prepubertal vitiligo.

Conclusions: Our data present clinical evidence that vitiligo behaves mostly the same way in both groups except that pre-pubertal onset vitiligo is strongly associated with a family history of vitiligo and a personal history of atopy, suggesting that it has a stronger hereditary component and immunological milieu than post-pubertal vitiligo.

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
2384 Views
442 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved